These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33541428)

  • 21. Beneficial role of adipose-derived mesenchymal stem cells from microfragmented fat in a murine model of duchenne muscular dystrophy.
    Bouglé A; Rocheteau P; Briand D; Hardy D; Verdonk F; Tremolada C; Hivelin M; Chrétien F
    Muscle Nerve; 2019 Sep; 60(3):328-335. PubMed ID: 31228273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic delivery of allogenic muscle stem cells induces long-term muscle repair and clinical efficacy in duchenne muscular dystrophy dogs.
    Rouger K; Larcher T; Dubreil L; Deschamps JY; Le Guiner C; Jouvion G; Delorme B; Lieubeau B; Carlus M; Fornasari B; Theret M; Orlando P; Ledevin M; Zuber C; Leroux I; Deleau S; Guigand L; Testault I; Le Rumeur E; Fiszman M; Chérel Y
    Am J Pathol; 2011 Nov; 179(5):2501-18. PubMed ID: 21924229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual AAV Gene Therapy for Duchenne Muscular Dystrophy with a 7-kb Mini-Dystrophin Gene in the Canine Model.
    Kodippili K; Hakim CH; Pan X; Yang HT; Yue Y; Zhang Y; Shin JH; Yang NN; Duan D
    Hum Gene Ther; 2018 Mar; 29(3):299-311. PubMed ID: 28793798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BMP4 inhibits myogenic differentiation of bone marrow-derived mesenchymal stromal cells in mdx mice.
    Jiqing C; Yaqin L; Yingyin L; Fei C; Huili Z; Yuling Z; Juan Y; Shanwei F; Cheng Z
    Cytotherapy; 2015 Sep; 17(9):1213-9. PubMed ID: 26276004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy.
    Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC
    PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Current status and perspective of gene therapy on dystrophic animal model].
    Takeda S
    Rinsho Shinkeigaku; 2004 Nov; 44(11):911-3. PubMed ID: 15651329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment.
    Hayashita-Kinoh H; Guillermo PH; Nitahara-Kasahara Y; Kuraoka M; Okada H; Chiyo T; Takeda S; Okada T
    Mol Ther Methods Clin Dev; 2021 Mar; 20():133-141. PubMed ID: 33426145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of myostatin promotes myogenic differentiation of rat bone marrow-derived mesenchymal stromal cells.
    Geng J; Peng F; Xiong F; Shang Y; Zhao C; Li W; Zhang C
    Cytotherapy; 2009; 11(7):849-63. PubMed ID: 19903098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
    Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M; Malik M; Langa P; Cwykiel J; Brodowska S; Heydemann A
    Stem Cell Rev Rep; 2019 Dec; 15(6):827-841. PubMed ID: 31612351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
    Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
    Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies.
    Yugeta N; Urasawa N; Fujii Y; Yoshimura M; Yuasa K; Wada MR; Nakura M; Shimatsu Y; Tomohiro M; Takahashi A; Machida N; Wakao Y; Nakamura A; Takeda S
    BMC Cardiovasc Disord; 2006 Dec; 6():47. PubMed ID: 17140458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression.
    Wang Z; Kuhr CS; Allen JM; Blankinship M; Gregorevic P; Chamberlain JS; Tapscott SJ; Storb R
    Mol Ther; 2007 Jun; 15(6):1160-6. PubMed ID: 17426713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
    Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
    Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin.
    Vieira NM; Valadares M; Zucconi E; Secco M; Bueno CR; Brandalise V; Assoni A; Gomes J; Landini V; Andrade T; Caetano HV; Vainzof M; Zatz M
    Cell Transplant; 2012; 21(7):1407-17. PubMed ID: 23168016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.
    Sun C; Shen L; Zhang Z; Xie X
    Genes (Basel); 2020 Jul; 11(8):. PubMed ID: 32717791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.
    Pelatti MV; Gomes JP; Vieira NM; Cangussu E; Landini V; Andrade T; Sartori M; Petrus L; Zatz M
    Stem Cell Rev Rep; 2016 Aug; 12(4):448-53. PubMed ID: 27193781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.